Cargando…

Elevated serum Cripto‐1 and VEGF levels in patients with non‐small cell lung cancer

Cripto‐1 (CR‐1) facilitates vascular endothelial growth factor (VEGF) expression, and these markers are associated with various tumor cell proliferation, angiogenesis, and metastasis. The main aim of our study was to investigate the clinical value of CR‐1 and VEGF for non‐small cell lung cancer (NSC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Chunhua, Zou, Jue, Li, Li, Yuan, Qi, Wang, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353448/ https://www.ncbi.nlm.nih.gov/pubmed/35949510 http://dx.doi.org/10.1096/fba.2022-00002

Ejemplares similares

Expression of Cripto‐1 predicts poor prognosis in stage I non‐small cell lung cancer
por: Xu, Chunhua, et al.
Publicado: (2020)

Elevated expression of Cripto-1 correlates with poor prognosis in hepatocellular carcinoma
por: Wang, Jia-hong, et al.
Publicado: (2015)

CRIPTO Is a Marker of Chemotherapy-Induced Stem Cell Expansion in Non-Small Cell Lung Cancer
por: Francescangeli, Federica, et al.
Publicado: (2022)

Cripto-1 in TNBC
por: Castro, Nadia P, et al.
Publicado: (2015)

Prognostic significance of serum osteopontin levels in small cell lung cancer
por: Xu, Chunhua, et al.
Publicado: (2020)

High level of serum Cripto-1 in hepatocellular carcinoma, especially with hepatitis B virus infection
por: Zhang, Yingyu, et al.
Publicado: (2018)

Serum VEGF levels in the early diagnosis and severity assessment of non-small cell lung cancer
por: Lai, Yanzhen, et al.
Publicado: (2018)

Clinical significance of cripto-1 expression in lung adenocarcinoma
por: Zhang, Hua, et al.
Publicado: (2017)

Evaluation of serum and pleural levels tumor M2-pyruvate kinase in lung cancer patients with pleural effusion
por: Zhang, Tiantian, et al.
Publicado: (2022)

Assessing the Prognostic Value of the Neutrophil-to-Lymphocyte Ratio in Stage I Non-Small-Cell Lung Cancer with Complete Resection
por: Liu, Wei, et al.
Publicado: (2022)

Genetic Variants Modulating CRIPTO Serum Levels Identified by Genome-Wide Association Study in Cilento Isolates
por: Ruggiero, Daniela, et al.
Publicado: (2015)

Expression of cripto in Human Pancreatic Tumors
por: Tsutsumi, Masahiro, et al.
Publicado: (1994)

Serum tumour M2‐pyruvate kinase as a biomarker for diagnosis and prognosis of early‐stage non–small cell lung cancer
por: Xu, Chunhua, et al.
Publicado: (2021)

Elevated VEGF levels contribute to the pathogenesis of osteoarthritis
por: Yuan, Quan, et al.
Publicado: (2014)

Cripto-1 overexpression is involved in the tumorigenesis of nasopharyngeal carcinoma
por: Wu, Zhengrong, et al.
Publicado: (2009)

Autoregulation and Heterogeneity in Expression of Human Cripto-1
por: Loying, Pojul, et al.
Publicado: (2015)

CRIPTO-1 Is Immunolocalized in the Syncytiotrophoblast of Ampullary Pregnancies
por: Cabar, Fábio Roberto, et al.
Publicado: (2022)

The prognostic value of pretreatment albumin-to-fibrinogen ratio in small cell lung cancer patients receiving first-line platinum-based chemotherapy
por: Li, Qi, et al.
Publicado: (2023)

Evaluation of diagnostic and predictive values of the serum VEGF-A level and systemic immune-inflammation index in small cell lung cancer
por: Yao, Jing-hao, et al.
Publicado: (2021)

Expression and functional role of CRIPTO-1 in cutaneous melanoma
por: De Luca, A, et al.
Publicado: (2011)

Cripto haploinsufficiency affects in vivo colon tumor development
por: GIORGIO, EMILIA, et al.
Publicado: (2014)

Beneficial effects of Cripto-1 for transarterial chemoembolization in hepatocellular carcinoma
por: Li, Xiao-shan, et al.
Publicado: (2019)

Serum macrophage inhibitory cytokine‐1 as a clinical marker for non–small cell lung cancer
por: Xu, Chunhua, et al.
Publicado: (2021)

Serum pleiotrophin as a diagnostic and prognostic marker for small cell lung cancer
por: Xu, Chunhua, et al.
Publicado: (2019)

Exosomal Cripto-1 Serves as a Potential Biomarker for Perihilar Cholangiocarcinoma
por: Hu, Chunxiao, et al.
Publicado: (2021)

Cripto-1 as a Potential Target of Cancer Stem Cells for Immunotherapy
por: Ishii, Hiroko, et al.
Publicado: (2021)

Enhancement of Notch receptor maturation and signaling sensitivity by Cripto-1
por: Watanabe, Kazuhide, et al.
Publicado: (2009)

Whence CRIPTO: The Reemergence of an Oncofetal Factor in ‘Wounds’ That Fail to Heal
por: Freeman, David W., et al.
Publicado: (2021)

The Value of Computed Tomography-Guided Percutaneous Lung Biopsy Combined With Rapid On-Site Evaluation in Diagnosis of Peripheral Pulmonary Nodules
por: Liu, Wei, et al.
Publicado: (2022)

Dynamic regulation of the cancer stem cell compartment by Cripto-1 in colorectal cancer
por: Francescangeli, F, et al.
Publicado: (2015)

Cripto-1 as a novel therapeutic target for triple negative breast cancer
por: Castro, Nadia P., et al.
Publicado: (2014)

Exogenous Cripto-1 Suppresses Self-Renewal of Cancer Stem Cell Model
por: Alam, Md Jahangir, et al.
Publicado: (2018)

New Insights into Cancer Targeted Therapy: Nodal and Cripto-1 as Attractive Candidates
por: Arboretto, Paola, et al.
Publicado: (2021)

Clinical Efficacy of Osimertinib in Patients with Advanced Non-Small Cell Lung Cancer and Its Effect on Serum CEA and VEGF Expression
por: Wang, Huanyuan, et al.
Publicado: (2022)

Tumorigenic Factor CRIPTO-1 Is Immunolocalized in Extravillous Cytotrophoblast in Placenta Creta
por: Bandeira, Carla Letícia, et al.
Publicado: (2014)

Translational significance of Nodal, Cripto-1 and Notch4 in adult nevi
por: Strizzi, Luigi, et al.
Publicado: (2016)

Cripto-1 vaccination elicits protective immunity against metastatic melanoma
por: Ligtenberg, M. A., et al.
Publicado: (2016)

Expression of transforming growth factor alpha, amphiregulin and cripto-1 in human breast carcinomas.
por: Qi, C. F., et al.
Publicado: (1994)

Cripto-1 Promotes the Epithelial-Mesenchymal Transition in Esophageal Squamous Cell Carcinoma Cells
por: Huang, Chun, et al.
Publicado: (2015)

Prognostic significance of serum chemerin levels in patients with non-small cell lung cancer
por: Xu, Chun-Hua, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_bc7m1upetqcihjuj2gaqkiib07